Impact of implementing smart infusion pumps in a pediatric intensive care unit

Silvia Manrique-Rodríguez1, Amelia C Sánchez-Galindo, Jesús López-Herce

  • 1Silvia Manrique-Rodríguez, Pharm.D., Ph.D., is Clinical Hospital Pharmacist; Amelia C. Sánchez-Galindo, M.D., is Intensive Care Pediatrician; and Jesús López-Herce, M.D., Ph.D., is Intensive Care Pediatrician, Pediatric Intensive Care Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Miguel Ángel Calleja-Hernández, Pharm.D., Ph.D., is Director, Pharmacy Service, Hospital Universitario Virgen de las Nieves, Granada, Spain. Fernando Martínez-Martínez, Pharm.D., Ph.D., is University Professor, Faculty of Pharmacy, Campus de Cartuja, Granada. Irene Iglesias-Peinado, Pharm.D., Ph.D., is University Professor, Faculty of Pharmacy, Universidad Complutense de Madrid, Madrid. Ángel Carrillo-Álvarez, M.D., Ph.D., is Director, Pediatric Intensive Care Unit, Hospital General Universitario Gregorio Marañón. María Sanjurjo Sáez, Pharm.D., is Director; and Cecilia M. Fernández-Llamazares, Pharm.D., Ph.D., is Clinical Hospital Pharmacist, Pharmacy Service, Pediatric Intensive Care Unit, Hospital General Universitario Gregorio Marañón.

Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
216
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
429
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
796